Origin & tradition
Not traditional as a longevity supplement: betaine is derived from beets and sugar cane and has been used as an osmolyte in sport nutrition.
Western tradition · Methyl Donor
A potent methyl donor that clears homocysteine, sustains the SAM methylation cycle, and is increasingly paired with NMN in longevity stacks.
Data definition. Matched records include all indexed medical endpoints for this intervention — not only longevity. Longevity-relevant records are screened separately and cited in the evidence summary below. Counts are matched-record volumes, not de-duplicated trials and not efficacy claims.
Not traditional as a longevity supplement: betaine is derived from beets and sugar cane and has been used as an osmolyte in sport nutrition.
Key active: Trimethylglycine — methyl donor & osmolyte.
TMG donates methyl groups to homocysteine (converting it to methionine), lowering a key cardiovascular and aging biomarker. It co-factors the SAM (S-adenosylmethionine) cycle, relevant to DNA and histone methylation maintenance. Human RCTs confirm homocysteine lowering; emerging data cover muscle protein synthesis, liver fat, and athletic performance.
Effect summary
| Health outcome | Effect | Magnitude | Grade |
|---|---|---|---|
| Homocysteine levels | Decreases | Strong | A |
| Athletic power output | Increases | Moderate | B |
| Liver fat (NAFLD) | Decreases | Moderate | B |
| Methylation markers (SAM:SAH ratio) | Increases | Moderate | B |
| Body composition (lean mass) | Increases | Minor | C |
Grade: A = robust RCTs · B = several RCTs / meta-analysis · C = limited or mixed RCTs · D = observational or early data
Dosage guidance
TMG (betaine) is a methyl donor — lowers homocysteine by donating methyl groups. Common in beets, spinach, and wheat germ. At 2.5g/day in athletes, consistently improves power output and body composition. May raise LDL slightly at higher doses — monitor.
Informational only — not a prescription or personalised medical advice. Consult a qualified clinician before starting any supplement or medication.
Evidence summary
Human RCTs on homocysteine and athletic performance; epigenetic aging trials emerging
TMG donates methyl groups to homocysteine (converting it to methionine), lowering a key cardiovascular and aging biomarker. It co-factors the SAM (S-adenosylmethionine) cycle, relevant to DNA and histone methylation maintenance. Human RCTs confirm homocysteine lowering; emerging data cover muscle protein synthesis, liver fat, and athletic performance.
According to PubMed and ClinicalTrials.gov: trial counts from ClinicalTrials.gov, peer-reviewed literature from PubMed. Counts auto-refresh weekly; last checked 2026-09-13. They include trials across many endpoints, not only longevity.
Informational only — not medical advice, a treatment claim, or a substitute for a qualified clinician. Evidence strength varies; we show mixed and null results on purpose.
Evidence collections
Compare the evidence
The headline NAD+ booster of the longevity world — human trials show it raises blood NAD+ and may support physical function.
The leading NMN alternative — a direct NAD+ precursor with multiple RCTs confirming it safely raises NAD+ levels in humans.
The simplest and cheapest NAD+ precursor — with extensive human trial data in skin aging and DNA repair.
A flavone from parsley and chamomile that inhibits CD38 (NADase) — preserving NAD+ through a complementary mechanism to NMN or NR.
Suppliers
Tell us what you need and we will source suppliers for you.